In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci-Reference-Cited by-同舟云学术

In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci

Published:1987-02 Issue:2 Volume:31 Page:340-342
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Verbist L

Abstract

The activity of LY146032, a new lipopeptide antibiotic, was compared in vitro with those of vancomycin, oxacillin, and ampicillin against 261 staphylococcal and 154 streptococcal isolates. The MICs of LY146032 and vancomycin were similar, but the bactericidal activity and killing kinetics of LY146032 were more pronounced.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.31.2.340

Reference1 articles.

1. In vitro activity and mechanism of action of A21978CI, a novel cyclic lipopeptide antibiotic;Eliopoulos G. M., C.;Antimicrob. Agents Chemother.,1985

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin;Expert Review of Anti-infective Therapy;2023-02-10

2. A Decade of Research on Daptomycin;Synlett;2022-06-27

3. Controlled release of vancomycin from cross-linked gelatine;Journal of Materials Science: Materials in Medicine;2007-10-04

4. Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001;Antimicrobial Agents and Chemotherapy;2003-05

5. Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001;Journal of Antimicrobial Chemotherapy;2003-02-11